Tirzepatide emerges a groundbreaking treatment agent for individuals battling type 2 diabetes. As a dual stimulator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide https://mariyahxdry097792.blogdemls.com/40395589/tirzepatide-a-new-frontier-in-diabetes-treatment